Skip to main content
Canna~Fangled Abstracts

Cannabis and Migraine: It’s Complicated

By February 25, 2021No Comments
Patients utilizing medical cannabis for migraine have reported improvement in migraine profile and common comorbidities. Reduction in prescription medication is also common, especially opioids.
Review
. 2021 Feb 25;25(3):16.

doi: 10.1007/s11916-020-00931-2.

Laszlo L Mechtler1, Fran M Gengo2, Vincent H Bargnes3
Affiliations 

Abstract

Purpose of review: The use of cannabis for the treatment of migraine has become an area of interest with the legalization of medical cannabis in the USA. Understanding the mechanisms of cannabinoids, available studies, and best clinical recommendations is crucial for headache providers to best serve patients.

Recent findings: Patients utilizing medical cannabis for migraine have reported improvement in migraine profile and common comorbidities. Reduction in prescription medication is also common, especially opioids. Side effects exist, with the majority being mild. Not enough data is available for specific dose recommendations, but THC and CBD appear to mediate these observed effects. The purpose of this article is twofold: review the limited research surrounding cannabis for migraine disease and reflect on clinical management experiences to provide recommendations that best capture the potential use of cannabis for migraine.

 

Keywords: Cannabis, Headache, Marijuana, Medical cannabis, Medical marijuana, Migraine

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain [Internet]. 2018 Feb 21 [cited 2020 Jul 29];19(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821623/
    1. • Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA. Migraine and the trigeminovascular system—40 years and counting. Lancet Neurol. 2019 Aug 1;18(8):795–804. Review on migraine pathophysiology.
    1. Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain. 2013 Dec;154(Suppl 1):S44–53. – PubMed – DOI
    1. Xu X, Liu Y, Dong M, Zou D, Wei Y. Tricyclic antidepressants for preventing migraine in adults. Medicine (Baltimore) [Internet]. 2017 Jun 2 [cited 2020 Jul 18];96(22). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459715/
    1. Naegel S, Obermann M. Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference. Neuropsychiatr Dis Treat. 2010;6:17–28. – PubMed – PMC

Publication types

Leave a Reply